Related content

Pioglitazone and metformin in obese women with polycystic ovary syndrome not optimally responsive to metformin

By Glueck Charles J.   Moreira Andrew   Goldenberg Naila   Sieve Luann   Wang Ping  

Human Reproduction, Vol. 18, Iss. 8, 2003-08 ,pp. : 1618-1625

Oxford University Press

Access to resources Recommend Favorite

Reproductive endocrinology. Insulin sensitivity in non-obese women with polycystic ovary syndrome during treatment with oral contraceptives containing low-androgenic progestin

By Cibula D.  

Human Reproduction, Vol. 17, Iss. 1, 2002-01 ,pp. : 76-82

Oxford University Press

Access to resources Recommend Favorite

Reproductive endocrinology. Follistatin and activin A serum concentrations in obese and non-obese patients with polycystic ovary syndrome

By Eldar-Geva T.  

Human Reproduction, Vol. 16, Iss. 12, 2001-12 ,pp. : 2552-2556

Oxford University Press

Access to resources Recommend Favorite

Low-dose pioglitazone, flutamide, metformin plus an estro-progestagen for non-obese young women with polycystic ovary syndrome: increasing efficacy and persistent safety over 30 months

By Ibáñez Lourdes   López-bermejo Abel   Díaz Marta   Enríquez Goya   Del Río Luis   De Zegher Francis  

Gynecological Endocrinology, Vol. 26, Iss. 12, 2010-12 ,pp. : 869-873

Informa Healthcare

Access to resources Recommend Favorite

Increased follistatin levels after oral contraceptive treatment in obese and non-obese women with polycystic ovary syndrome

By Chen Mei-Jou   Yang Wei-Shiung   Chen Hsin-Fu   Kuo Jahn-Jahn   Ho Hong-Nerng   Yang Yu-Shih   Chen Shee-Uan  

Human Reproduction, Vol. 25, Iss. 3, 2010-03 ,pp. : 779-785

Oxford University Press

Access to resources Recommend Favorite